Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Published by: Babson College
Originally published in: 2002
Version: 14 March 2002
Length: 16 pages
Data source: Published sources

Abstract

This is the fifth of an eight-case series (301-146-1 to 301-149-1 and 302-037-1 to 302-040-1). This case describes UK-based Glaxo Wellcome. During the period 1998-1999, the company focused on respiratory, anti-viral, and central nervous system research. Other areas of research included cardiovascular, oncology, critical care, and metabolic diseases such as diabetes. The case offers a summary of activity in these key areas. Revenue and balance sheet information is also provided. One in a series of eight cases drawn from public information sources. May be used alone or with others in the series Global Biotechnology Winners. Suitable for graduate MBA and executive level courses in strategy, corporate strategy, and strategy relating to biotechnology and pharmaceuticals.
Location:
Industry:
Size:
USD13.25 billion
Other setting(s):
1999

About

Abstract

This is the fifth of an eight-case series (301-146-1 to 301-149-1 and 302-037-1 to 302-040-1). This case describes UK-based Glaxo Wellcome. During the period 1998-1999, the company focused on respiratory, anti-viral, and central nervous system research. Other areas of research included cardiovascular, oncology, critical care, and metabolic diseases such as diabetes. The case offers a summary of activity in these key areas. Revenue and balance sheet information is also provided. One in a series of eight cases drawn from public information sources. May be used alone or with others in the series Global Biotechnology Winners. Suitable for graduate MBA and executive level courses in strategy, corporate strategy, and strategy relating to biotechnology and pharmaceuticals.

Settings

Location:
Industry:
Size:
USD13.25 billion
Other setting(s):
1999

Related